alnylam overview
Published 6 years ago • 142 plays • Length 2:29Download video MP4
Download video MP3
Similar videos
-
3:12
alnylam overview and it's focus on rna interference
-
1:05
alnylam pharma and the science of rnai
-
3:14
alnylam pharmaceuticals cmo, dr. akshay vaishnaw, explains rnai
-
1:01
alnylam's new rnai therapy
-
2:32
what is rnai and how do rnai-based medicines work?
-
2:19
get to know alnylam - the leader in rnai therapeutics
-
2:09
alnylam's clinical focus
-
1:16
alnylam, and the ph1 community, waiting for the fda to approve lumasiran
-
44:31
breaking down evalgen: who validates the validators?
-
1:34
lensar ascrs 2022 - ally™ system demos
-
3:26
first approved treatment using rnai – alnylam pharmaceuticals’ and bio chair john maraganore
-
1:29
how alnylam works with patient advocacy groups
-
0:44
alnylam - a rare disease company
-
1:07
alnylam's pending approval of patisiran
-
2:17
ensure more accurate detection
-
15:44
how alnylam is finally translating rnai into breakthrough medicines? alny stock is soaring
-
1:58
hereditary attr amyloidosis overview
-
2:15
dr. pushkal garg discusses alnylam's rare disease day initiatives